/ / /
Rob brings more than 20 years of financial and commercial experience in heading global finance operations. Rob was Chief Financial Officer of Verastem Oncology, a biopharmaceutical company focused on advancing cancer therapeutics. Previously, Rob was Chief Financial Officer at Harvard Bioscience, Inc, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine. Prior to this, he served as Executive Vice President, Chief Financial Officer, and Treasurer at Clean Harbors, Inc as well as Chief Accounting Officer and Controller at Biogen Idec, Inc.
Earlier, he worked in a variety of senior positions at Deloitte & Touche, LLP, and Price Waterhouse Coopers, LLP. He holds an MBA from the MIT Sloan School of Management and a Bachelor of Arts degree in accounting from Bentley College.